How much funding has BenchSci raised?

BenchSci has raised $265.2M in total funding, most recently a Series D round.

Who are BenchSci's investors?

BenchSci's investors include Inovia Capital, Generation Investment Management, TCV, F-Prime Capital, Two Small Fish Ventures, Golden Ventures.

Where is BenchSci headquartered?

BenchSci is headquartered in Toronto, Ontario, Canada.

What industry is BenchSci in?

BenchSci operates in Artificial Intelligence, Drug Discovery, Biotech, Life Sciences.

How many employees does BenchSci have?

BenchSci has 201-500 employees.

BenchSci

formerly Scinapsis Analytics

Unlocking the Black Box of Disease Biology

Toronto, Canada · Founded 2015 · $265.2M raised

Artificial Intelligence

Drug Discovery

Biotech

Life Sciences

Headquarters: Toronto, Ontario
Employees: 201–500
Founded: 2015
Business Model: SaaS

Website: benchsci.com
Total Funding: $265.2M
Last Round: $70.0M Series DMay 2023
Rounds: 8

About

BenchSci is a world leader in AI solutions for preclinical R&D, using proprietary neurosymbolic AI to decode disease biology. The platform integrates a Biological Evidence Knowledge Graph with foundation models to provide AI copilots that accelerate hypothesis testing and drug discovery from years to days. It combines public, licensed, and internal data for biopharma teams.

Summary

BenchSci is an Artificial Intelligence company based in Toronto, Canada, founded in 2015. It has raised $265.2M in total across 8 rounds, most recently a $70.0M Series D round in May 2023. Investors include Inovia Capital, Generation Investment Management and TCV.

LinkedIn X (Twitter)GitHub